Estera Okon
Chodzki 1 St
Lublin, LU 20093, Poland
Lublin, LU 20093, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Purification of Lepidilines A, B, C, and D from Lepidium meyenii Walpers by Centrifugal Partition Chromatography Followed by Semi-Preparative HPLC and Preliminary Evaluation of Anticancer Activity Against Neuroblastoma Cell Lines.
Journal: Molecules (Basel, Switzerland)
Published: October 06, 2025
Chemopreventive and Anticancer Activity of Selected Triterpenoids in Melanoma.
Journal: Cancers
Published: April 02, 2025
Selisistat, a SIRT1 inhibitor, enhances paclitaxel activity in luminal and triple-negative breast cancer: in silico, in vitro, and in vivo studies.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 12, 2025
The Activity of 1,8-Dihydroanthraquinone Derivatives in Nervous System Cancers.
Journal: Molecules (Basel, Switzerland)
Published: November 27, 2024
Vaccinium Species-Unexplored Sources of Active Constituents for Cosmeceuticals.
Journal: Biomolecules
Published: August 09, 2024
Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer.
Journal: International journal of molecular sciences
Published: October 09, 2023
Emodin-8-O-Glucoside-Isolation and the Screening of the Anticancer Potential against the Nervous System Tumors.
Journal: Molecules (Basel, Switzerland)
Published: September 17, 2023
Advancements in Zebrafish Models for Breast Cancer Research: Unveiling Biomarkers, Targeted Therapies, and Personalized Medicine.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: July 02, 2023
Antagonistic Pharmacological Interaction between Sirtuin Inhibitor Cambinol and Paclitaxel in Triple-Negative Breast Cancer Cell Lines: An Isobolographic Analysis.
Journal: International journal of molecular sciences
Published: May 24, 2022
Additive pharmacological interaction between sirtuin inhibitor cambinol and paclitaxel in MCF7 luminal and MDA-MB-231 triple-negative breast cancer cells.
Journal: Pharmacological reports : PR
Published: April 10, 2022
Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells.
Journal: Cells
Published: February 13, 2022
Last Updated: 09/26/2026